Interaction between homocysteine and lipoprotein(a) increases the prevalence of coronary artery disease/myocardial infarction in women: A case-control study

Thrombosis Research

Volumn 129, Issue 2, 2012, Pages 133-138

  Balogh, Emilia ^a   Bereczky, Zsuzsanna ^a   Katona, Éva ^a   Koszegi, Zsolt ^a   Édes, István ^a   Muszbek, László ^a,b   Czuriga, István ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Coronary artery disease; Homocysteine; Interaction; Lipoprotein(a); Myocardial infarction; Women

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; LIPOPROTEIN A;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; FEMALE; GENDER; GENE FREQUENCY; HEART INFARCTION; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RISK FACTOR;

AGED; BIOLOGICAL MARKERS; COMORBIDITY; CORONARY ARTERY DISEASE; FEMALE; HOMOCYSTEINE; HUMANS; HUNGARY; LIPOPROTEIN(A); MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION; STATISTICS AS TOPIC;

EID: 84855893003     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.07.001     Document Type: Article

References (39)

1. K.S. McCully Vascular pathology of homocysteinaemia: implications for the pathogenesis of arteriosclerosis Am J Pathol 56 1969 111 128
2. L.L. Humphrey, R. Fu, K. Rogers, M. Freeman, and M. Helfand Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis Mayo Clin Proc 83 2008 1203 1212
3. H. Jakubowski The molecular basis of homocysteine thiolactone-mediated vascular disease Clin Chem Lab Med 45 2007 1704 1716 (Pubitemid 350232966)
4. D.L. Sauls, E. Lockhart, M.E. Warren, A. Lenkowski, S.E. Wilhelm, and M. Hoffman Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinaemia Biochemistry 28 45 2006 2480 2487
5. A. Undas, J. Perla, M. Lacinski, W. Trzeciak, R. Kazmierski, and H. Jakubowski Autoantibodies against N-homocysteinylated proteins in humans: implications for atherosclerosis Stroke 35 2004 1299 1304 (Pubitemid 38697447)
6. A. Bennet, E. Di Angelantonio, S. Erqou, G. Eiriksdottir, G. Sigurdsson, and M. Woodward Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data Arch Intern Med 168 2008 598 608 (Pubitemid 351468395)
7. M.L. Koschinsky Novel insights into Lp(a) Physiology and Pathogenicity: More Questions Than Answers? Cardiovasc Haematol Disord Drug Targets 6 2006 267 278 (Pubitemid 44890588)
8. E.G. Levin, L.A. Miles, G.M. Fless, A.M. Scanu, P. Baynham, and L.K. Curtiss Lipoproteins inhibit the secretion of tissue plasminogen activator from human endothelial cells Arterioscler Thromb 14 1994 438 442
9. O.R. Etingin, D.P. Hajjar, K.A. Hajjar, P.C. Harpel, and R.L. Nachman Lipoprotein(a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. A potential mechanism in thrombogenesis J Biol Chem 266 1991 2459 2465 (Pubitemid 21909085)
10. T. Syrovets, J. Thillet, M.U. Chapman, and T. Simmet Lipoprotein(a) is a potent chemoattractant for human peripheral monocytes Blood 90 1997 2027 2036 (Pubitemid 27377316)
11. S. Takami, S. Yamashita, S. Kihara, M. Ishigami, K. Takemura, and N. Kume Lipoprotein(a) enhances the expression of intercellular adhesion molecule-1 in cultured human umbilical vein endothelial cells Circulation 97 1998 721 728 (Pubitemid 28135333)
12. T. Ichikawa, H. Unoki, H. Sun, H. Shimoyamada, S. Marcovina, and H. Shikama Lipoprotein(a) promotes smooth muscle cell proliferation and differentiation in atherosclerotic lesions of human apo(a) transgenic rabbits Am J Pathol 160 2002 227 236 (Pubitemid 34052283)
13. H.U. Milionis, D.P. Mikhalidis, and A.F. Winder Platelets and lipoprotein(a): a brief overview of their role in the pathogenesis of atherothrombosis Platelets 10 1999 277 284 (Pubitemid 29490853)
14. J.A.M. Foody, J.A. Milberg, K. Robinson, G.L. Pearce, D.W. Jacobsen, and D.L. Sprecher Homocysteine and lipoprotein(a) interact to increase CAD risk in young men and women Thromb Vasc Biol 20 2000 493 499 (Pubitemid 30086108)
15. R.K. Dhamija, P. Gaba, S. Arora, A. Kaintura, M. Kumar, and J. Bhattacharjee Homocysteine and lipoprotein (a) correlation in ischemic stroke patients J Neurol Sci 281 2009 64 68
16. J.S. Hochman, J.E. Tamis, T.D. Thompson, W.D. Weaver, H.D. White, and F. Van de Werf Sex, clinical presentation, and outcome in patients with acute coronary syndromes N Engl J Med 341 1999 226 232 (Pubitemid 29334520)
17. M. Stramba-Badiale, K.M. Fox, S.G. Priori, P. Collins, C. Daly, and I. Graham Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology Eur Heart J 27 2006 994 1005
18. A. Lerman, and G. Sopko Women and cardiovascular heart disease: Clinical implications from the womens ischemia syndrome evaluation (WISE) study J Am Coll Cardiol 47 2006 S59 S62
19. H. Jneid, G.C. Fonarow, C.P. Cannon, A.F. Hernandez, I.F. Palacios, and A.O. Maree Sex differences in medical care and early death after acute myocardial infarction Circulation 118 2008 2803 2810
20. A.A. Quyyumi Women and ischemic heart disease. Pathophysiologic implications from the Womens Ishemia Syndrome Evaluation (WISE) study and future research steps J Am Coll Cardiol 47 2006 S66 S71
21. Z. Bereczky, E. Balogh, E. Katona, Z. Pocsai, I. Czuriga, and G. Széles Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the high risk Hungarian population Thromb Res 120 4 2007 567 573 (Pubitemid 47103195)
22. The Joint European Society of Cardiology/American College of Cardiology Committee Myocardial infarction redefined- A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction Eur Heart J 21 2000 1502 1513
23. H. Refsum, A.D. Smith, P.M. Ueland, E. Nexo, R. Clarke, and J. McPartlin Facts and recommendations about total homocysteine determinations: An expert opinion Clin Chem 50 2004 3 32 (Pubitemid 38125696)
24. C.J. Boushey, S.A. Beresford, G.S. Omenn, and A.G. Motulsky A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes JAMA 274 1995 1049 1057
25. P.M. Ridker, C.H. Hennekens, J.E. Buring, and N. Rifai C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 2000 836 843 (Pubitemid 30165206)
26. P. Knekt, G. Alfthan, A. Aromaa, M. Heliovaara, J. Marniemi, and H. Rissanen Homocysteine and major coronary events: a prospective population study amongst women J Intern Med 249 2001 461 465 (Pubitemid 34208950)
27. D.E. Zylberstein, C. Bengtsson, C. Björkelund, S. Landaas, V. Sundh, and D. Thelle Serum homocysteine in relation to mortality and morbidity from coronary heart disease Circulation 109 2004 601 606
28. J.H. Page, J. Ma, S.E. Chiuve, M.J. Stampfer, J. Selhub, and J.E. Manson Plasma total cysteine and total homocysteine and risk of myocardial infarction in women: A prospective study Am Heart J 159 2010 599 604
29. S. Sadeghian, F. Fallahi, M. Salarifar, G. Davoodi, M. Mahmoodian, and N. Fallah Homocysteine, vitamin B12 and folate levels in premature coronary artery disease BMC Cardiovasc Disord 6 2006 38 44
30. The Emerging Risk Factors Collaboration Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality JAMA 302 2009 412 423
31. P.R. Kamstrup, M. Benn, A. Tybjaerg-Hansen, and B.G. Nordestgaard Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study Circulation 117 2008 176 184
32. S. Kiechl, J. Willeit, M. Mayr, B. Viehweider, M. Oberhollenzer, and F. Kronenberg Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholiase A2 activity and 10-year cardiovascular outcomes: prospective results from the Bruneck study Arterioscler Thromb Vasc Biol 27 2007 1788 1795 (Pubitemid 47207175)
33. R.K. Dhamija, P. Gaba, S. Arora, A. Kaintura, M. Kumar, and J. Bhattacharjee Homocysteine and lipoprotein (a) correlation in ischaemic stroke patients J Neurol Sci 281 2009 64 68
34. P.N. Hopkins, L.L. Wu, S.C. Hunt, B.C. James, G.M. Vincent, and R.R. Williams Lipoprotein(a) interactions with lipid and nonlipid risk factors in early familial coronary artery disease Arterioscler Thromb Vasc Biol 17 1997 2783 2792 (Pubitemid 28016022)
35. P.C. Harpel, V.T. Chang, and W. Borth Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: A potencial biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism Proc Natl Acad Sci U S A 89 1992 10193 10197
36. P.C. Harpel, A. Hemann, X. Zhang, I. Ostfeld, and W. Borth Lipoprotein(a), plasmin modulation, and atherogenesis Thromb Haemost 74 1995 382 386
37. A.M. Scanu, L.A. Miles, G.M. Flesh, D. Pfaffinger, J. Eisenhart, and E. Jackson Rhesus monkey lipoprotein(a) binds to lysine Sepharose and U937 monocytoid cells less efficiently than human lipoprotein(a): evidence for the dominant role of kringle 4(37) J Clin Invest 91 1993 283 291 (Pubitemid 23037283)
38. S.N. Sotiriou, V.V. Orlova, N. Al-Fakhri, E. Ihanus, M. Economopoulou, and B. Isermann Lipoprotein(a) in atherosclerotic plaques recruits inflammatory cells through interaction with Mac-1 integrin FASEB J 20 2006 559 561 (Pubitemid 46671249)
39. L. Muszbek, Z. Bereczky, Z. Bagoly, A.H. Shemirani, and E. Katona Factor XIII and atherothrombotic diseases Semin Thromb Hemost 36 2010 18 33